AWM Investment Company, Inc.

908 Devices Inc. develops handheld devices for point-of-need chemical analysis. The company utilizes mass spectrometry (Mass Spec) and optical spectroscopy, analytics, and machine learning technologies to create devices that are smaller and more accessible than traditional laboratory instruments. These devices are designed for use at the point-of-need to analyze unknown and invisible materials, providing quick, actionable answers for critical applications in health, safety, and defense technology. Specific applications include addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The company's products, or devices, include the MX908, ThreatID, ProtectIR, XplorIR, and VipIR. These simplified measurement devices serve as accurate tools for customers, enabling analysis where and when work needs to be done, rather than relying on complex, centralized analytical instrumentation. Since launching its first device in 2014, 908 Devices Inc. has sold more than 3,700 handheld devices to over 700 customers, including various domestic and foreign government agencies. Front-line workers use these Mass Spec handheld devices to combat the opioid crisis and detect counterfeit pharmaceuticals and illicit materials in the air or on surfaces at levels as low as 1,000 times below their lethal dose. Mass Spec is a standard analytical technology for laboratory-based molecular analysis, identifying and quantifying sample components through molecular weight measurements, and is known for detailed analysis of various samples.